C12 Galactosylceramide (d18:1/12:0) (Synonyms: N-Dodecanoyl-β-D-Galactosylceramide, Galactosylceramide (d18:1/12:0), GalCer(d18:1/12:0)) |
Catalog No.GC43007 |
C12 Galactosylceramide is a bioactive sphingolipid.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 41613-14-3
Sample solution is provided at 25 µL, 10mM.
C12 Galactosylceramide is a bioactive sphingolipid. It inhibits IL-4 production by 53.84% in EL4 T cells when used at a concentration of 10 μM. C12 Galactosylceramide reduces the growth of human papillomavirus type 16-associated tumors in mice and reduces tumor recurrence following surgical removal or chemotherapy. It also reduces natural killer T cell activity, delays the onset of proteinuria, and improves survival in a mouse model of systemic lupus.
Average Rating: 5
(Based on Reviews and 2 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *